Electromed, Inc. (ELMD)
NYSEAMERICAN: ELMD · Real-Time Price · USD
18.13
-0.08 (-0.44%)
At close: Aug 1, 2025, 4:00 PM
18.13
0.00 (0.00%)
After-hours: Aug 1, 2025, 6:30 PM EDT
Verve Therapeutics Market Cap
Electromed has a market cap or net worth of $152.04 million as of August 1, 2025. Its market cap has increased by 14.49% in one year.
Market Cap
152.04M
Enterprise Value
136.80M
1-Year Change
14.49%
Ranking
Category
Stock Price
$18.13
Market Cap Chart
Since August 13, 2010, Electromed's market cap has increased from $32.60M to $152.04M, an increase of 366.38%. That is a compound annual growth rate of 10.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 152.70M | -38.90% |
| Dec 31, 2024 | 249.90M | 166.99% |
| Dec 29, 2023 | 93.60M | 5.17% |
| Dec 30, 2022 | 89.00M | -20.11% |
| Dec 31, 2021 | 111.40M | 31.99% |
| Dec 31, 2020 | 84.40M | 15.46% |
| Dec 31, 2019 | 73.10M | 72.00% |
| Dec 31, 2018 | 42.50M | -15.17% |
| Dec 29, 2017 | 50.10M | 57.05% |
| Dec 30, 2016 | 31.90M | 105.81% |
| Dec 31, 2015 | 15.50M | -28.24% |
| Dec 31, 2014 | 21.60M | -21.74% |
| Dec 31, 2013 | 27.60M | 150.91% |
| Dec 31, 2012 | 11.00M | -60.57% |
| Dec 30, 2011 | 27.90M | -2.79% |
| Dec 31, 2010 | 28.70M | -11.96% |
| Aug 13, 2010 | 32.60M | - |
View and export this data all the way back to 2010. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 682.35B |
| Johnson & Johnson | 402.82B |
| AbbVie | 334.40B |
| UnitedHealth Group | 241.34B |
| AstraZeneca | 236.88B |
| Novartis AG | 227.02B |
| Abbott Laboratories | 223.66B |
| Novo Nordisk | 221.96B |